Core View - Class action lawsuits have been filed on behalf of shareholders of several publicly-traded companies, with deadlines for filing lead plaintiff motions approaching [1] Varonis Systems, Inc. (NASDAQ: VRNS) - Class period is from February 4, 2025, to October 28, 2025, with a lead plaintiff deadline of March 9, 2026 [2] - Allegations include that Varonis was not equipped to sustain its Annual Recurring Revenue (ARR) growth without high quarterly conversions, making positive statements about its business misleading [2] Ardent Health, Inc. (NYSE: ARDT) - Class period is from July 18, 2024, to November 12, 2025, with a lead plaintiff deadline of March 9, 2026 [3] - Allegations state that Ardent misrepresented its accounts receivable framework and did not maintain sufficient malpractice liability insurance, leading to misleading positive statements about its operations [3] CoreWeave, Inc. (NASDAQ: CRWV) - Class period is from March 28, 2025, to December 15, 2025, with a lead plaintiff deadline of March 13, 2026 [4] - Allegations include overstating the company's ability to meet customer demand and underestimating risks associated with reliance on a single third-party data center supplier, resulting in misleading statements about its business [4] Bath & Body Works, Inc. (NYSE: BBWI) - Class period is from June 4, 2024, to November 19, 2025, with a lead plaintiff deadline of March 16, 2026 [5] - Allegations indicate that the company's strategy for growth was ineffective, leading to reliance on brand collaborations to mask weak financial results, which were misleadingly presented [5]

New York, New York--(Newsfile Corp. - January 23, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against Ardent Health, Inc. (NYSE: ARDT) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws. If you invested in Ardent Health, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-heal ...

NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Ardent Health, Inc. ("Ardent Health, Inc." or the "Company") (NYSE: ARDT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ardent Health, Inc. investors who were adversely affected by alleged securities fraud between July 18, 2024 and November 12, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/ar ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Ardent Health, Inc. securities between July 18, 2024, and November 12, 2025, of the March 9, 2026, deadline to become a lead plaintiff in a class action lawsuit [1] Group 1: Class Action Details - Investors who purchased Ardent Health securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by March 9, 2026, to serve as lead plaintiff [2] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm specializes in securities class actions and has a strong track record, including the largest securities class action settlement against a Chinese company [3] - The firm has been ranked No. 1 for securities class action settlements in 2017 and has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 [3] Group 3: Case Allegations - The lawsuit alleges that Ardent Health made misrepresentations regarding its accounts receivable, claiming an active monitoring process that was not actually employed [4] - Defendants downplayed issues related to increased claim denials by third-party payors and did not write off uncollectible accounts, leading to inflated accounts receivable figures [4] - Ardent Health's professional liability reserves were insufficient to cover claims, contrary to their public statements about maintaining adequate insurance [4]

BENSALEM, Pa., Jan. 22, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Ardent Health, Inc. ("Ardent" or the "Company") (NYSE: ARDT). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ARDENT HEALTH, INC. (ARDT), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE MARCH 9, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. Contact the Law Offices o ...

SAN FRANCISCO, Jan. 22, 2026 (GLOBE NEWSWIRE) -- National shareholder rights firm Hagens Berman is notifying Ardent Health, Inc. (NYSE: ARDT) investors that a securities class action lawsuit has been filed against the company and certain of its executives following the company’s disastrous Q3 2025 financial results. Hagens Berman is investigating the alleged claims that Ardent misled investors about its revenue recognition systems and the adequacy of its professional liability reserves. The firm urges inves ...

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of Ardent Health, Inc. related to misrepresentation and failure to disclose critical financial information [1][2]. Group 1: Allegations of Misrepresentation - Insiders at Ardent Health allegedly misrepresented the company's reliance on "detailed reviews of historical collections" for determining the collectability of accounts receivable [2]. - The accounts receivable framework reportedly utilized a "180-day cliff," allowing Ardent Health to report inflated accounts receivable and postpone recognizing losses on uncollectible accounts [2]. - It was disclosed that Ardent Health did not maintain sufficient professional malpractice liability insurance to cover claims arising from its operations [2]. Group 2: Shareholder Involvement - Shareholders who purchased ARDT prior to July 18, 2024, are encouraged to contact Kuehn Law to enforce their rights, as there may be limited time to act [2]. - The firm emphasizes the importance of shareholder participation in maintaining the integrity and fairness of financial markets [3].

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Ardent Health, Inc. (NYSE: ARDT). Shareholders who purchased shares of ARDT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/ardent-health-inc-loss-submission-form/?id=183202&from=4 CLASS PERIOD: July 18, 202 ...

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1]. Group 1: Lawsuit Details - The lawsuit was filed by Bleichmar Fonti & Auld LLP on behalf of investors in Ardent Health securities, asserting claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [3]. - Investors have until March 9, 2026, to request to be appointed to lead the case, which is pending in the U.S. District Court for the Middle District of Tennessee [3]. Group 2: Allegations Against Ardent Health - The lawsuit alleges that Ardent Health misrepresented its process for determining the collectability of accounts receivable, claiming it relied on "detailed reviews of historical collections," while in reality, it utilized a "180-day cliff" method [4]. - This misrepresentation allowed Ardent Health to report inflated accounts receivable and delay recognizing losses on uncollectable accounts, constituting a violation of federal securities laws [4]. Group 3: Stock Price Impact - On November 12, 2025, Ardent Health disclosed a $43 million revenue decrease for the quarter and a $54 million increase in professional liability reserves, leading to a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 [5].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardent To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Ardent between July 18, 2024 and November 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. - January 21, 2026) ...